Overview
MDL | MFCD00005844 |
---|
Molecular Weight | 430.08 |
---|
Molecular Formula | C10H10BrN5NaO6P |
---|
SMILES | NC1=C(N=C(Br)N2[C@@H]3O[C@@](COP(O4)([O-])=O)([H])[C@]4([H])[C@H]3O)C2=NC=N1.[Na+] |
---|
For research use only.
Storage
3 years,-20°C,powder
1 years,-80°C,in solvent
Shipping
Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)
Preparing Stock Solutions
| 1 mg | 5 mg | 10 mg |
1 mM | 2.3251 mL | 11.6257 mL | 23.2515 mL |
5 mM | 0.4650 mL | 2.3251 mL | 4.6503 mL |
10 mM | 0.2325 mL | 1.1626 mL | 2.3251 mL |
50 mM | 0.0465 mL | 0.2325 mL | 0.4650 mL |
Description
8-bromo-cAMP (8-Br-Camp) is a cell permeable analog of that activates cyclic-AMP-dependent protein kinase with a Ka value of 0.05 μM; and a activator.
In vitro
8-Bromo-cAMP improves the reprogramming efficiency of human neonatal foreskin fibroblast (HFF1) cells. In bronchial epithelial cells, 8-Bromo-cAMP decreases HDE-stimulated tumor necrosis factor (TNF)-α-converting enzyme (TACE; ADAM-17) activity and subsequent TNF-α release.